Latest News
Pfizer Receives European Approval for Zirabev, a Biosimilar to Avastin
21 February 2019 - - The European Commission has approved Zirabev for the treatment of metastatic carcinoma of the colon or rectum, metastatic breast cancer, unresectable advanced, metastatic or recurrent non-small cell lung cancer (NSCLC), advanced ...
Gamida Cell Inks Agreement with Editas Medicine to Evaluate Use of CRISPR Genome Editing Technology in NAM-NK Cells
21 February 2019 - - US-based cellular and immune therapeutics company Gamida Cell Ltd. (NASDAQ: GMDA) has forged an agreement with genome editing company Editas Medicine, Inc to evaluate the potential use of Editas Medicine's CRISPR techno...
Alvogen unveils generic Suboxone (Buprenorphine/Naloxone) sublingual film
21 February 2019 - Pharmaceutical company Alvogen revealed on Wednesday the availability of its generic equivalent of Suboxone sublingual film (buprenorphine hydrochloride/naloxone hydrochloride) in the US in 2mg/0.5 mg, 4mg/1mg, 8 mg/2mg and 12mg/3m...
Beacon Health Options names new Northeast market president
21 February 2019 - Beacon Health Options, a behavioural health management company, announced yesterday that it has named Susan Coakley as its new Northeast market president.Coakley was the former President of Boston Medical Center HealthNet Plan. She...
Versant Health names new senior director, Sales Operations
21 February 2019 - Versant Health, a national managed eye health and vision plan company, has named Josh Ellis as its new senior director, Sales Operations it was reported yesterday.The company said that Ellis has more than 14 years of successful sal...